注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Steven G. Gourlay | 62 | 2021 | MD, CEO & Director |
Alan Keith Boyd | 66 | - | Member of Scientific Advisory Board |
Geoffrey Edward Duncan Brooke | 65 | 2017 | Independent Non-Executive Chairman |
Christina Kurre Olsen | - | 2022 | Member of Depression & Cognition Clinical Advisory Board |
Christopher Chen | - | 2022 | Member of Depression & Cognition Clinical Advisory Board |
Jeffrey L. Cummings | 73 | 2015 | Member of Xanamem Clinical Advisory Board |
Jonathan Seckl | - | - | Member of Scientific Advisory Board |
Malcolm John McComas | 68 | 2019 | Independent Non-Executive Director |
Brian R. Walker | - | - | Member of Scientific Advisory Board |
Craig W. Ritchie | - | 2015 | Chairman of Xanamem Clinical Advisory Board |
Colin Louis Masters | 76 | 2015 | Member of Xanamem Clinical Advisory Board |
George Morstyn | 73 | 2017 | Independent Non-Executive Director |
Scott Webster | - | - | Member of Scientific Advisory Board |
John Harrison | - | 2022 | Member of Depression & Cognition Clinical Advisory Board |
Nicki Vasquez | 59 | 2023 | Independent Non-Executive Director |
Dana C. Hilt | 70 | 2022 | Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核